Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study
- 21 October 2009
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 72 (6), 359-369
- https://doi.org/10.1159/000249164